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Reproducibility of ambulatory blood pressure
changes from the initial values on two different days
Garrett I. Ash, Timothy J. Walker, Kayla M. Olson, Jeffrey H. Stratton, Ana L. Go´mez, William J. Kraemer,
Jeff S. Volek, Linda S. Pescatello
University of Connecticut, Department of Kinesiology & Human Performance Laboratory, Storrs/Connecticut, United States.
OBJECTIVE: We tested the reproducibility of changes in the ambulatory blood pressure (BP) from the initial
values, an indicator of BP reactivity and cardiovascular health outcomes, in young, healthy adults.
METHOD: The subjects wore an ambulatory BP monitor attached by the same investigator at the same time of
day until the next morning on two different days (day 1 and day 2) separated by a week. We compared the
ambulatory BP change from the initial values at hourly intervals over 24 waking and sleeping hours on days 1
and 2 using linear regression and repeated measures analysis of covariance.
RESULTS: The subjects comprised 88 men and 57 women (mean age¡SE 22.4¡0.3 years) with normal BP
(118.3¡0.9/69.7¡0.6 mmHg). For the total sample, the correlation between the ambulatory BP change on day
1 vs. day 2 over 24, waking, and sleeping hours ranged from 0.37–0.61; among women, the correlation was
0.38–0.71, and among men, it was 0.24–0.52. Among women, the ambulatory systolic/diastolic BP change was
greater by 3.1¡1.0/2.4¡0.8 mmHg over 24 hours and by 3.0¡1.1/2.4¡0.8 mmHg over waking hours on day 1
than on day 2. The diastolic ambulatory BP change during sleeping hours was greater by 2.2¡0.9 mmHg on day
1 than on day 2, but the systolic ambulatory BP change during sleeping hours on days 1 and 2 did not differ.
Among men, the ambulatory BP change on days 1 and 2 did not differ.
CONCLUSION: Our primary findings were that the ambulatory BP change from the initial values was moderately
reproducible; however, it was more reproducible in men than in women. These results suggest that women, but
not men, may experience an alerting reaction to initially wearing the ambulatory BP monitor.
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& INTRODUCTION
Ambulatory blood pressure (BP) monitoring is the stan-
dard clinical method for assessing BP status. Ambulatory BP
predicts cardiovascular outcomes and target organ damage,
assesses circadian BP patterns, and monitors the response to
antihypertensive medication (1,2). However, evidence sug-
gests the prognostic value of ambulatory BP monitoring may
be limited to the degree of reproducibility of the BP
measurements made on different days (3).
Ambulatory BP reproducibility is defined as the standard
deviation of the difference between two BP measurements
made on two different days for the same individual.
Ambulatory BP reproducibility can also be defined by the
coefficient of variation, which is the standard deviation of
the difference expressed as a percentage of the mean value
of the BP measurements made on two different days. The
reported reproducibility between ambulatory BP measure-
ments made on different days differs among studies. For
example, the mean standard deviation of the difference in
ambulatory BP readings made on two separate days over 24
hours for the same subject has been found to range from 7–
13 mmHg for systolic and 3–8 mmHg for diastolic ambula-
tory BP (4–13). Differences in subject characteristics, such as
BP status and age, may explain these apparent inconsis-
tencies and the poor reproducibility of ambulatory BP.
Another feature of these studies that could contribute to
poor ambulatory BP reproducibility is the long interval of
time, typically 3 months or longer, that is often employed
between BP measurements (6,8,10,13). In studies that use a
long interval between ambulatory BP measurements,
reproducibility could be modulated by extraneous factors
such as season (14), changes in body weight (1,13), and
alterations in adherence to lifestyle behavior patterns and
pharmacological therapies used to treat hypertension (1).
There is also evidence that the reproducibility of BP
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measurements may be compromised by an alerting reaction
to initially wearing the monitor (4,9,11–13,15,16). An
alerting reaction is defined as a higher ambulatory BP
reading on the first measurement than on the second caused
by anxiety and sleep disturbances due to initially wearing
the monitor; these disturbances typically diminish upon
subsequent ambulatory BP assessments.
We undertook the present study to quantify reprodu-
cibility in the change in ambulatory BP from initial values,
an indicator of BP reactivity and predictor of cardiovas-
cular health outcomes (17,18), and the average ambulatory
BP on 2 separate days 1 week apart in a sample of young,
healthy adults with normal BP. We hypothesized that
ambulatory BP would be higher on the first day than on
the second.
& METHODS
Subjects
The participants were recruited from a larger study
entitled ‘‘Investigation of whey protein supplementation
for physiologic enhancement to resistance training and
dietary regimes in young adults’’ (REPS) (National Dairy
Council 070996). REPS participants were healthy adults 18–
35 years of age who had not participated in any resistance
training programs during the past year and had resting
BP ,150/95 mmHg. Prior to participating in REPS, the
subjects signed an informed consent form approved by the
Institutional Review Board of the University of Connecticut.
Upon enrollment, waist circumference was measured at the
narrowest part of the torso using a standard flexible tape
with a spring-loaded handle (Gulick 4192G, G&S Fibreflex,
San Diego, CA). Height was measured with a stadiometer
(Seca, Hamburg, Germany), and weight with a calibrated
digital scale (OHAUS, Florham Park, NJ). Additionally, the
body mass index (BMI) was calculated. Prior to the
resistance training and nutrition supplement intervention,
the participants were asked to complete two separate
ambulatory BP monitoring studies on two different days
separated by one week. The ambulatory BP data served as
the basis for this sub-study.
Procedures
All ambulatory BP monitoring visits occurred in the
morning between 7:00 and 11:00 am (mean¡standard error
9:09 am¡0:06). The standard procedures used in our
previous ambulatory BP studies (2,19–21) were followed
and were performed by the same trained investigator at the
same time of day for each subject. The subjects were
instructed to refrain from formal exercise and caffeine,
respectively, 24 hours prior to and the morning of the
attachment. Laboratory visits were postponed if the subject
was ill, unusually busy or anxious or planned to spend
unusual amounts of time in a motorized vehicle the day of
the scheduled attachment. Upon entering the laboratory, the
subjects were seated for at least 15 minutes. The investigator
took a minimum of three BP readings by auscultation in
each arm separated by one minute, alternating between the
arms, until three auscultatory readings in each arm agreed
within 5 mmHg. The investigator then fitted the subject
with an appropriately sized BP cuff and attached the
Accutracker II automatic non-invasive ambulatory BP
monitor (SunTech Medical Instruments Inc., Raleigh, NC).
Upon attachment of the monitor, a calibration check was
performed using a mercury sphygmomanometer (W.A.
Baum Co. Inc., New York, NY) with a t-tubule (2). When
three ambulatory BP measurements within 5 mmHg of the
auscultatory measurements had been recorded, the ambu-
latory BP measurements were averaged and reported as the
initial BP value for that day.
Upon leaving the laboratory, the subjects were instructed
to proceed with normal activities, not to shower or exercise
until the next morning, and to keep their arms still and
extended when ambulatory BP measurements were being
taken. The subjects were asked to carry a standard journal,
recording activities performed during each measurement,
any unusual physical or emotional events, and sleep and
wake times. They were also asked to limit driving while
wearing the ambulatory BP monitor; if driving was
necessary, they were to rest the cuffed arm against the
body at heart level while a reading was being taken.
The ambulatory BP monitor was programmed to record
the ambulatory BP every 20 minutes during waking hours
and every 30 minutes during sleeping hours to minimize
sleep disturbance. The monitor obtained a second reading if
there was a difference between consecutive readings of
systolic ambulatory BP.50 mmHg, diastolic.40 mmHg, or
pulse pressure.50 mmHg. The ambulatory BP recordings
were acceptable if the monitor obtained at least 80% of the
potential BP readings. Investigators omitted readings if the
values met the manufacturer’s exclusion criteria of systolic
ambulatory BP.220 or ,80 mmHg or diastolic.130 or
,40 mmHg.
The ambulatory BP readings taken during each hourly
interval were averaged to determine the average ambula-
tory BP for each hour. In the rare instances in which an
hourly average interval of ambulatory BP readings was
missing, the investigators averaged the BP values from the
hours before and after the missed hour to represent the
missing data. The initial ambulatory BP was then subtracted
from the average ambulatory BP at each hourly time
interval to calculate the ambulatory BP change. The 15
hours when the subjects were awake and ambulating
represented the waking hours, the 9 hours when the
subjects were sleeping represented the sleeping hours, and
the 15 waking plus the 9 sleeping hours represented 24
hours. The average and ambulatory BP changes from the
initial value were calculated for days 1 and 2 over 24 hours,
the waking hours, and the sleeping hours.
Statistical analysis
Descriptive statistics were generated for all dependent
and independent variables. Analysis of variance was used
to test for differences in the subject descriptive character-
istics between the sexes. We used the following statistical
methods to assess the reproducibility of the average and
ambulatory BP change from the initial value on days 1 vs. 2
over 24 hours, the waking hours and the sleeping hours: 1)
Pearson correlation coefficients; 2) repeated measures
analysis of covariance by sex with BMI and age as
covariates; and 3) standard deviation of the difference and
coefficient of variation.
Significance was set at p,0.05, and all data were reported
as the mean¡standard error. All analyses were performed
using the Statistical Package for Social Sciences Base 14.0 for
Windows (SPSS Inc., Chicago, IL).
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& RESULTS
Subjects
The characteristics of the participants (57 women, 88 men)
are shown in Table 1. Age, BMI, waist circumference, and
resting ambulatory diastolic BP were not different between
sexes (p$0.05). However, the resting ambulatory systolic BP
was greater in the men than in the women (p,0.001). The
two different ambulatory BP measurements were separated
by an average of 7.9¡0.6 days.
Measures of ambulatory BP reproducibility
Pearson correlation coefficients. Table 2 displays the
Pearson correlation coefficients of the ambulatory BP
change from the initial value and the average ambulatory
BP on day 1 vs. day 2 over 24 hours, the waking hours, and
the sleeping hours. The correlation between the average
ambulatory BP change on day 1 vs. day 2 over 24 hours, the
waking hours, and the sleeping hours ranged from 0.37–0.61
(p,0.001) in the total sample, 0.38–0.71 (p,0.05) in women,
and 0.24–0.52 (p,0.01) in men. The correlation between the
average ambulatory BP on days 1 and 2 over 24 hours, the
waking hours, and the sleeping hours ranged from 0.62–0.82
(p,0.001) in the total sample, 0.74–0.87 (p,0.001) in women,
and 0.50–0.73 in men (p,0.001).
Repeated measures analysis of covariance. Table 3
displays the initial BP, the ambulatory BP change from the
initial value, the average ambulatory BP, and the mean
differences in these values on day 1 vs. day 2 over 24 hours,
the waking hours, and the sleeping hours in the total sample
and by sex. The initial BP was not different on days 1 and 2
in the total sample or by sex (p$0.05).
Among the total sample, the ambulatory BP change from
the initial value was greater on day 1 than on 2 over 24
hours for the systolic and diastolic BP (p= 0.007 and 0.027,
respectively). In addition, the systolic (p= 0.019) but not the
diastolic (p$0.05) ambulatory BP change during the waking
hours was greater on day 1 than on day 2. The ambulatory
BP change from the initial value over the sleeping hours did
not differ on days 1 and 2 (p$0.05). The average ambulatory
BP over 24 hours was greater on day 1 than on day 2 for
both the systolic and diastolic BP (p= 0.007 and p= 0.008,
respectively). In addition, the average systolic ambulatory
BP over the waking (p= 0.014) and sleeping (p= 0.047) hours
was greater on day 1 than on day 2, but the average diastolic
ambulatory BP over the waking hours did not differ on the 2
days (p$0.05).
Among women, the ambulatory BP change for the systolic
and diastolic BP was greater on day 1 than on day 2 over 24
hours (p= 0.004 and p= 0.003, respectively) and over the
waking hours (p= 0.007 and p = 0.004, respectively)
(Figure 1). In addition, the women’s diastolic (p= 0.011)
but not systolic (p$0.05) ambulatory BP change over the
sleeping hours was greater on day 1 than on day 2. Their
average ambulatory systolic and diastolic BP was greater on
day 1 than on day 2 over 24 hours (p = 0.005 and p= 0.024,
respectively) and during the waking hours (p = 0.014 and
p= 0.039, respectively), and their average systolic (p= 0.014)
but not diastolic (p$0.05) ambulatory BP was greater on day
1 than on 2 during the sleeping hours. In contrast, among
Table 1 - Physical characteristics (mean¡standard error) of the study sample by sex.
Total (n = 145) Women (n =57) Men (n=88)
Age (yr) 22.4¡0.3 22.5¡0.5 22.3¡0.4
BMI (kg*m22) 25.2¡0.4 25.1¡0.6 25.2¡0.4
Waist Circumference (cm) 78.0¡0.9 72.8¡1.4 81.4¡1.1
Resting Systolic Blood Pressure (mmHg) 118.3¡0.9 112.3¡1.3 122.3¡0.9*
Resting Diastolic Blood Pressure (mmHg) 69.7¡0.6 68.9¡1.1 70.3¡0.7
BMI-body mass index; *p,0.001 women vs. men. The resting systolic/diastolic blood pressure was calculated as the average of the initial systolic/diastolic
blood pressure on days 1 and 2.
Table 2 - Pearson correlation coefficients between the initial blood pressure, ambulatory blood pressure change from the initial
value, and average ambulatory blood pressure on day 1 vs. day 2 over 24 hours, the waking hours, and the sleeping hours.
Total (n = 145) Women (n =57) Men (n=88)
Initial
SBP 0.80 0.78 0.73
DBP 0.70 0.82 0.61
Ambulatory BP Change from Initial Values
24 hour SBP 0.40 0.41* 0.40
24 hour DBP 0.42 0.52 0.38
Awake SBP 0.37 0.38{ 0.38
Awake DBP 0.39 0.47 0.36
Sleep SBP 0.61 0.71 0.52
Sleep DBP 0.39 0.63 0.24{
Average Ambulatory BP
24 hour SBP 0.82 0.85 0.72
24 hour DBP 0.79 0.87 0.73
Awake SBP 0.81 0.84 0.70
Awake DBP 0.76 0.85 0.68
Sleep SBP 0.71 0.74 0.60
Sleep DBP 0.62 0.78 0.50
All correlations p,0.001 unless indicated: *p=0.001, {p=0.003, {p=0.024. SBP-systolic blood pressure; DBP-diastolic blood pressure.
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men, the ambulatory BP change from the initial value and
the average ambulatory BP did not differ on days 1 and 2
over 24 hours, the waking hours, and the sleeping hours
(p$0.05).
Standard deviation of the difference and coefficient of
variation. Table 3 also reports the standard deviation of
the difference and the coefficient of variation for the initial
BP, the ambulatory BP change from the initial value, and the
average ambulatory BP on days 1 vs. 2 over 24 hours, the
waking hours and the sleeping hours in the total sample and
by sex. The standard deviation of the difference in the
ambulatory BP change from the initial value on day 1 vs.
day 2 over 24 hours, the waking hours, and the sleeping
hours ranged from 3.6–4.9 mmHg in the total sample, 3.4–
4.6 mmHg in women, and 3.8–5.3 mmHg in men. The
standard deviation of the difference in the average
ambulatory BP on day 1 vs. day 2 over 24 hours, the
waking hours, and the sleeping hours ranged from 2.2–
4.5 mmHg in the total sample, 2.1–3.8 mmHg in women,
and 2.3–4.9 mmHg in men.
The coefficient of variation between the average ambula-
tory BP on day 1 vs. day 2 over 24 hours, the waking hours,
and the sleeping hours ranged from 2.6–4.5% in the total
sample, 2.5–4.5% in women, and 2.7–5.8% in men. We do
not report the coefficient of variation for the ambulatory BP
change because the ambulatory BP change adjusts for the
initial BP values, as does the coefficient of variation.
& DISCUSSION
Our primary findings were that the average ambulatory
BP was strongly reproducible and that the ambulatory BP
change from the initial value was moderately reproducible
when measured in young, healthy subjects with normal BP
on 2 different days separated by 1 week. An unexpected
finding was that the average ambulatory BP was 1–2 mmHg
higher and the ambulatory BP change from the initial value
was 2–3 mmHg higher on day 1 vs. day 2 among the women
but not among the men. This finding suggests that women,
but not men, may have experienced an alerting reaction to
initially wearing the ambulatory BP monitor (15,16).
Our study is unique because we assessed not only the
reproducibility of average ambulatory BP but also ambula-
tory BP change from initial value as indicators of reprodu-
cibility. Based upon strength of the correlations reported in
Table 2 and the smaller standard deviation of the difference
reported in Table 3, average ambulatory BP appears to be
more reproducible than ambulatory BP change. Stergiou
and Parati (18) recently stated that the ambulatory BP
change from the initial value, which they termed ‘BP
reactivity’, was a better indicator of the physiologic
response to wearing an ambulatory BP monitor under
conditions of daily living than average ambulatory BP.
Furthermore, evidence suggests that BP reactivity predicts
cardiovascular health outcomes independent of initial BP
value (17). For example, the Coronary Artery Risk
Development in Young Adults (CARDIA) study measured
the BP change from the initial value among young adult
women and men in response to playing a video game (22).
The CARDIA investigators found that for each 10 mmHg
systolic BP increase from the initial value, there was a 24%
increased likelihood of developing subsequent coronary
artery calcification within 13 years. Thus, determining the
reproducibility of not only the measurement of average
ambulatory BP but also the ambulatory BP change from the
initial value appears to be important.
Our study confirms the findings reported in the existing
literature that the average ambulatory BP is strongly
reproducible among study populations with normal BP
regardless of whether the ambulatory BP measurements are
separated by several weeks (11) or months (8). We found
that the standard deviation of the difference in the average
ambulatory BP ranged from 2–4 mmHg and that its
coefficient of variation ranged from 3–5% among the
subjects in our study who had normal BP (Table 3). In
contrast, studies that included subjects with hypertension
found higher standard deviation of the difference values
ranging from 4–13 mmHg, independent of whether ambu-
latory BP measurements were separated by several weeks
(4,5,7,9,12) or by several months (6,10,13). The greater BP
variability among individuals with a higher BP is consi-
stent with recent findings that visit-to-visit (23,24) and
Figure 1 - Average waking ambulatory blood pressure change from the initial value at hourly intervals over 15 hours on 2 different days
separated by 1 week among women.
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within-visit (25) BP variability for resting BP correlates
positively with BP status.
The higher ambulatory BP readings observed on day 1 vs.
day 2 among women but not among men suggest that the
women, but not the men, experienced an alerting reaction to
initially wearing the monitor (15,16). Shin et al. (25) found
that women exhibited greater within-visit auscultatory BP
variability than men, including greater differences between
the initial and subsequent BP measurements; this effect was
considered to result from an alerting reaction to the initial
auscultatory BP measurement. Calvo et al. (15) found that
when women and men with hypertension wore an
ambulatory BP monitor continuously for 48 hours, the
average ambulatory BP over 24 hours and the waking hours
was lower on the second day than on the first day.
Consistent with these findings, Palatini et al. (13) reported
that when women and men with hypertension completed
two ambulatory BP monitoring studies separated by three
months, the average ambulatory BP declined by 1 mmHg.
Similarly, Musso et al. (16) found that when women and
men with a normal BP completed four ambulatory BP
monitoring studies, each separated by one week, the
average ambulatory BP declined approximately 1 mmHg
with each successive weekly measurement, reaching statis-
tical significance by the fourth week. Trazzi et al. (4) and
Coats et al. (12) also documented trends in ambulatory BP
reductions between successive readings, although the
reductions did not reach statistical significance.
Our study is the first to show that an alerting reaction
appears to be gender-dependent and that such a reaction
can significantly affect the reproducibility of ambulatory BP.
These findings are relevant to both clinical practice and
research. For our results indicate that a familiarization
ambulatory BP session should occur prior to any clinical
decision making regarding the interpretation of the BP
response to an experimental perturbation, and perhaps the
effectiveness of antihypertensive therapy. A difference in
the BP response of 2–3 mmHg, such as we found between
the first and second ambulatory BP monitoring studies,
could be mistakenly attributed to experimental intervention
or antihypertensive treatment when, in fact, it might be due
to an alerting reaction to wearing the ambulatory BP
monitor for the first time (26).
A question raised by our findings of a sex-dependent
response is why an alerting reaction was experienced by the
women but not by the men. Steptoe et al. (27) found that
men exhibited a greater BP response to mental stress
interventions administered in the laboratory than did
women. Furthermore, laboratory experiments indicate that
sympathetic nerve activity is positively associated with BP
in men; however, if an association is found among women,
it is in the opposite direction to that of men (28,29). In
addition, it would seem the men in our study would be
more susceptible to experiencing greater BP variability
between ambulatory BP measurements made on different
days due to having higher resting BP than the women (23–
25). Collectively, these data suggest that the men in our
study would have been more likely to experience an alerting
reaction to initially wearing the ambulatory BP monitor,
whereas we observed the opposite.
Previous studies addressing ambulatory BP reproduci-
bility on 2 different days have not found sex differences,
possibly due to the use of small sample sizes (4,6–12) and/
or the use of intervals of 3 months or longer between the BP
measurements (6,8,10,13). However, Muntner et al. (23)
found that women exhibited higher day-to-day variability
in auscultatory systolic BP than men, findings that are
consistent with ours. Similarly, Shin et al. (25) found that
women exhibited a higher within-visit variability in
auscultatory systolic and diastolic BP measurements than
men. State anxiety (30), psychological distress (31), and
social alienation (31) influence BP more strongly in women
than in men and may drive the sex differences in BP
variability. Sex differences in state anxiety also partially
explain the higher ‘white-coat hypertension’ among women
than men (30,32,33). Although we did not measure
sympathetic nerve activity, the differences we observed in
ambulatory BP on day 1 vs. day 2 were not accompanied by
significant differences in the heart rate (p$0.05, data not
shown), suggesting that sex-dependent differences in
sympathetic nerve activity do not account for our findings.
Hypothalamic-pituitary-adrenal cortical stress reactivity
directly correlates with BP stress reactivity (34) and is
higher among women than men (35). Therefore, sex
differences in cortical system stress reactivity are a plausible
physiological mechanism that may underlie the sex differ-
ences in the day-to-day BP variability that we and others
have observed (23,25,30,32,33). Future mechanistic studies
are required to evaluate this possibility and to evaluate
other possible mechanisms.
A major limitation of our study is that, on average, our
subjects had normal BP. We do not know whether our
findings regarding the lower reproducibility of ambulatory
BP in women than in men are generalizable to individuals
with hypertension. Several investigators found a higher
ambulatory BP on day 1 vs. day 2 among subjects with
hypertension but no sex differences in the reproducibility,
possibly due to the use of small sample sizes (4,9,12) and/or
long (3-month) intervals between BP measurements (13).
Based on previous reports that ambulatory BP reproduci-
bility is lower (4–7,9,10,12,13) and overall BP variability is
higher (23–25) in subjects with hypertension than in subjects
with normal BP (8,11), we would expect the ambulatory BP
to be even less reproducible among women with hyperten-
sion than we found to be the case for young women with
normal BP. However, further work is needed to determine
whether this supposition is correct.
In summary, the average ambulatory BP was strongly
reproducible, and the ambulatory BP change from the initial
value was moderately reproducible in a large sample of
young adults with normal BP. A new and unexpected
finding was that women, but not men, experienced an
alerting reaction of 1–3 mmHg during the initial period of
wearing the ambulatory BP monitor. Our observations
support the contention that visit-to-visit variability in BP is
affected more in women than in men by integrated, complex
physiological responses to psychosocial factors (18). The
effect we observed could be mitigated by the inclusion of a
familiarization ambulatory BP measurement performed
prior to the measurements aimed at evaluating the effects
of experimental interventions or treatments.
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